Skip to main content

Table 1 Sociodemographic, clinical and psychological characteristics of the study sample (n = 3347)

From: Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy

  n %
Sociodemographic factors
Age at survey (years) M = 78.1, SD = 6.3
   ≤ 70 375 11.2
   > 70 ≤ 80 1599 47.8
   > 80 1373 41.0
Educational level
  primary, secondary - low 1187 39.8
  secondary - intermediate 519 17.4
  secondary - high 362 12.2
  tertiary 911 30.6
Partnership
  yes 3053 92.1
  no 260 7.9
Children
  0 376 11.5
   ≥ 1 2901 88.5
Clinical characteristics
Age at surgery (years) M = 62.5, SD = 6.1
   ≤ 55 399 11.9
   > 55 ≤ 65 1742 52.1
   > 65 1206 36.0
Time since surgery (years) M = 15.6, SD = 3.8
   ≤ 10 198 5.9
   > 10 ≤ 15 1425 42.6
   > 15 ≤ 20 1349 40.3
   > 20 375 11.2
Second primary cancer
  yes 430 12.9
  no 2917 87.1
Family history of PCa
  yes 1297 38.8
  no 2050 61.2
PSA level at diagnosis (ng/ml)
   ≤ 4 307 9.9
   > 4 ≤ 10 1870 60.1
   > 10 934 30.0
Gleason score
  2–6 1424 50.5
  7, 3 + 4 = 7, 4 + 3 = 7 1131 40.0
  8–10 269 9.5
Grading
  G I 133 4.1
  G II 2292 70.3
  G III 833 25.6
Organ-confined stage at RP
  yes 2343 71.0
  no 955 29.0
Biochemical recurrence during follow-up
  yes 1211 40.9
  no 1749 59.1
Biochemical recurrence at survey
  yes 572 20.0
  no 2295 80.0
Discontinued PSA follow-up
  yes 186 5.6
  no 3161 94.4
Ongoing treatment at survey
  yes 423 12.9
  no 2864 87.1
Psychosocial factors
PHQ-2 (depression screening)
  positive screening (≥3) 469 14.8
  negative screening (< 3) 2707 85.2
GAD-2 (anxiety disorder screening)
  positive screening (≥3) 360 11.4
  negative screening (< 3) 2798 88.6
Perceived severity of disease
  low 1448 45.0
  high 1770 55.0
Well-being
  low 1075 34.2
  high 2067 65.8
Benefit Finding
  low 1823 56.0
  high 1429 44.0
  1. Note: M mean, SD standard deviation, PCa prostate cancer, PSA prostate specific antigen, RP radical prostatectomy, PHQ patient health questionnaire, GAD general anxiety disorder